UBS AM’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.7M Buy
1,030,254
+1,028,580
+61,444% +$50.5M 0.01% 643
2026
Q1
$78.9K Buy
1,674
+1,253
+298% +$62.1K ﹤0.01% 2877
2025
Q4
$19.8K Sell
421
-841,186
-100% -$39M ﹤0.01% 2736
2025
Q3
$35.4M Buy
841,607
+674,654
+404% +$27.1M 0.01% 669
2025
Q2
$6.13M Sell
166,953
-761,922
-82% -$25.3M ﹤0.01% 1610
2025
Q1
$28.1M Buy
928,875
+161,510
+21% +$4.66M 0.01% 829
2024
Q4
$21.8M Buy
767,365
+410,868
+115% +$11.1M 0.01% 912
2024
Q3
$9.3M Buy
356,497
+286,292
+408% +$5.58M ﹤0.01% 1264
2024
Q2
$1.03M Buy
+70,205
New +$992K ﹤0.01% 2357

Other funds holding AHR

UBS AM's AHR Position: Q2 2026 in Review

UBS AM increased its American Healthcare REIT (AHR) stake by 61,444% in Q2 2026, buying an estimated $50.5M and bringing the position to 1,030,254 shares worth $53.7M. The position accounts for 0.01% of the portfolio, ranked #643.

UBS AM first reported a position in AHR in Q2 2024 and has held it in 9 quarters since. 568 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • UBS AM held 1,030,254 shares of American Healthcare REIT worth $53.7M as of Q2 2026.
  • UBS AM bought 1,028,580 American Healthcare REIT shares in Q2 2026, an estimated $50.5M.
  • American Healthcare REIT made up 0.01% of UBS AM's portfolio in Q2 2026, its #643 holding.
  • UBS AM first reported a position in American Healthcare REIT in Q2 2024 and has held it in 9 quarters since.
  • 568 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.